Combination of tofogliflozin and pioglitazone for NAFLD: Extension to the ToPiND randomized controlled trial

The incidence of nonalcoholic fatty liver disease (NAFLD) has recently increased and is related to obesity and the associated surge in type 2 diabetes mellitus (T2DM) and metabolic syndromes. This trial follows up on our previous work and forms part of the ToPiND study. We aimed to combine tofoglifl...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoneda, Masato, Kobayashi, Takashi, Honda, Yasushi, Ogawa, Yuji, Kessoku, Takaomi, Imajo, Kento, Nogami, Asako, Taguri, Masataka, Kirikoshi, Hiroyuki, Saito, Satoru, Nakajima, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426404/
https://www.ncbi.nlm.nih.gov/pubmed/35578445
http://dx.doi.org/10.1002/hep4.1993

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426404/
https://www.ncbi.nlm.nih.gov/pubmed/35578445
http://dx.doi.org/10.1002/hep4.1993

Ejemplares similares